A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.

This study has been withdrawn prior to enrollment.

Study NCT00269971 Information provided by Janssen-Ortho Inc., Canada

First Received: December 22, 2005 Last Updated: September 12, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	April 1999
Estimated Primary Completion Date:	No date given